Chinoin
 |
|
| Société Anonyme | |
| Traded as |
Euronext: SAN : SNY CAC 40 Component |
| Industry | Pharmaceuticals |
| Founded | 20 August 2004 (by acquisition) as Sanofi Aventis 6 May 2011 as Sanofi |
| Headquarters | 54, Rue La Boétie, 75008 Paris, France |
|
Area served
|
Worldwide |
|
Key people
|
Serge Weinberg (Chairman), Olivier Brandicourt (CEO), Jean-François Dehecq (Original Founder) |
| Products | Prescription and over-the-counter drugs for thrombosis, cardiovascular disease, diabetes, central nervous system disorders, oncology and internal medicine, vaccines (list...) |
| Revenue |
 €33.821 billion (2016) |
 €6.534 billion (2016) |
|
| Profit |
€4.8 billion (2016) |
| Total assets |
€104.672 billion (2016) |
| Total equity |
€57.724 billion (2016) |
|
Number of employees
|
110,000 (2016) |
| Subsidiaries |
Sanofi Pasteur Genzyme Shantha Biotechnics Chattem Zentiva Medley Nichi-Iko |
| Website | www |
Sanofi S.A. is a French multinational pharmaceutical company headquartered in Gentilly, France, as of 2013 the world's fifth-largest by prescription sales. The company was formed as Sanofi-Aventis in 2004 by the merger of Aventis and Sanofi-Synthélabo, which were each the product of several previous mergers. It changed its name to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 .
Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical drugs principally in the prescription market, but the firm also develops over-the-counter medication. The company covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines (it is the world's largest producer of the latter through its subsidiary Sanofi Pasteur).
Sanofi was founded in 1973 as a subsidiary of Elf Aquitaine (a French oil company subsequently acquired by Total), when Elf Aquitaine took control of the Labaz group, a pharmaceutical company. In 1993 Sanofi made a move into the Eastern Europe market by acquiring a controlling interest in Chinoin, a Hungarian drug company that had about US$104 million in sales in 1992. In that same year, Sanofi's made its first significant venture into the U.S., and strengthened its presence in Eastern Europe, by first partnering with Sterling Winthrop and then acquiring the prescription pharmaceuticals business in 1994. Sanofi was incorporated under the laws of France in 1994 as a société anonyme, a form of limited liability company.
...
Wikipedia